Loading...
OTCMQLIS
Market cap5mUSD
Dec 19, Last price  
0.27USD
Name

Qualis Innovations Inc

Chart & Performance

D1W1MN
OTCM:QLIS chart
P/E
—
P/S
135.69
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
222.52%
Rev. gr., 5y
-76.41%
Revenues
40k
0000055,049,482000040,175
Net income
-805k
L-49.83%
-9,134-3,323,417-13,007,493-2,856,327-351,965470,479-1,093,150-517,177-1,875,342-1,604,563-805,021
CFO
-77k
L-86.30%
-7,784-901,384-2,620,167-794,002-166,825-3,210,046-487,344-181,495-792,844-558,426-76,529

Profile

Qualis Innovations, Inc. focuses on the development, production, and distribution of pain management and other central nervous system (CNS) based solutions. Its lead product is SOLACE, a non-invasive medical device to use electromagnetic induction to generate deep heat below the surface of the skin to reduce and relieve pain. The company is headquartered in Chadds Ford, Pennsylvania.
URL
https://www.qualisinnovations.com
IPO date
Jul 23, 2012
Employees
Domiciled in
CN
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑12
Income
Revenues
40
 
Cost of revenue
240
578
1,589
Unusual Expense (Income)
NOPBT
(200)
(578)
(1,589)
NOPBT Margin
Operating Taxes
684
143
Tax Rate
NOPAT
(200)
(1,263)
(1,732)
Net income
(805)
-49.83%
(1,605)
-14.44%
(1,875)
262.61%
Dividends
Dividend yield
Proceeds from repurchase of equity
500
100
1,250
BB yield
Debt
Debt current
9
31
Long-term debt
Deferred revenue
Other long-term liabilities
31
Net debt
7
(39)
(528)
Cash flow
Cash from operating activities
(77)
(558)
(793)
CAPEX
(2)
Cash from investing activities
(2)
Cash from financing activities
9
100
1,250
FCF
499
(1,206)
(1,808)
Balance
Cash
2
70
528
Long term investments
Excess cash
422
70
528
Stockholders' equity
(4,422)
(3,617)
(2,697)
Invested Capital
3,908
3,872
3,467
ROIC
ROCE
38.90%
EV
Common stock shares outstanding
8,476
8,334
6,928
Price
Market cap
EV
EBITDA
(183)
(561)
(1,142)
EV/EBITDA
Interest
684
Interest/NOPBT